Dyadic International, Inc. and Proliant Health and Biologicals announce Recombinant Albumin Development and Commercialization Partnership JUPITER, Fla., June 28, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (NASDAQ: DYAI), announced today that they have entered into a development and commercialization partnership...

Bovine Serum Albumin Market to Surpass US$ 361.1 Million by 2028, Says Coherent Market Insights (CMI) SEATTLE, Sept. 20, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global bovine serum albumin market is estimated to be valued at US$ 291.7 million in 2021 and is expected to...